Download FREE Report Sample
Download Free sample
MARKET INSIGHTS
Global scleral contact lenses market size was valued at USD 318 million in 2024. The market is projected to grow from USD 357 million in 2025 to USD 714 million by 2032, exhibiting a CAGR of 12.6% during the forecast period.
Scleral contact lenses are specialized optical devices designed to vault over the corneal surface and rest on the sclera (white part of the eye). Unlike conventional contact lenses, these provide improved comfort and vision correction for patients with irregular corneas or severe dry eye syndrome. The product category includes both mini-scleral lenses (15-18mm diameter) and large-scleral lenses (18mm+ diameter), each serving distinct clinical needs.
Market growth is primarily driven by increasing prevalence of corneal disorders like keratoconus, which affects approximately 1 in 2,000 people globally. Furthermore, technological advancements in lens materials and manufacturing processes are enhancing oxygen permeability - a critical factor that previously limited adoption. Major players like Bausch Health and CooperVision are investing heavily in R&D to develop next-generation scleral lenses with improved fitting algorithms and customizability.
Rising Prevalence of Corneal Disorders Fueling Market Expansion
The global scleral contact lenses market is experiencing robust growth, largely driven by the increasing incidence of corneal disorders and irregular astigmatism. Conditions like keratoconus, which affects approximately 1 in 2,000 people globally, create substantial demand for specialized vision correction solutions. Unlike conventional contact lenses, scleral lenses vault over the irregular corneal surface, providing superior visual acuity and comfort for patients with complex ocular surface diseases. The growing geriatric population, more prone to dry eye syndrome and other corneal complications, further amplifies this demand. With nearly 30% of contact lens wearers experiencing discomfort from standard lenses, professionals are increasingly prescribing scleral alternatives for improved patient outcomes.
Technological Advancements in Lens Materials and Designs
To know more about market statistics, Download a FREE Sample copy
Continuous innovation in lens materials and manufacturing technologies represents another key market driver. Recent developments in gas-permeable polymers and advanced 3D printing techniques enable the production of customized scleral lenses with unparalleled precision. These next-generation materials allow for higher oxygen permeability - a critical factor reducing the risk of corneal hypoxia. The transition from traditional PMMA to modern silicone hydrogel and fluorosilicone acrylate materials has significantly improved wearing comfort and safety. Manufacturers are investing heavily in proprietary designs, such as wavefront-optimized optics and moisture-retaining surface treatments, making scleral lenses viable for a broader patient base. Such innovations are transforming what was once considered a niche product into mainstream ophthalmic solutions.
➤ For instance, the introduction of hybrid scleral lenses combining rigid center optics with soft peripheral skirts has expanded applications to include postoperative corneal rehabilitation and severe dry eye management.
Furthermore, growing awareness among eye care professionals about scleral lens benefits and increasing training programs are facilitating greater adoption rates worldwide. Professional associations now recognize scleral lens fitting as a specialized competency, establishing standardized fitting protocols that build practitioner confidence in recommending these solutions.
High Cost and Complex Fitting Process Limiting Accessibility
While demand grows, several barriers hinder broader market penetration. Scleral lenses typically cost 3-5 times more than standard contact lenses, with complete fitting procedures requiring multiple visits and specialized equipment. The average price point ranging from $1,500 to $4,000 per pair puts these lenses out of reach for many patients, particularly in price-sensitive emerging markets. Insurance coverage remains inconsistent, with many providers classifying scleral lenses as elective rather than medically necessary, despite their therapeutic benefits for corneal disorders. This financial burden creates significant adoption challenges, especially when compared to more affordable alternatives like glasses or conventional contacts.
Other Restraints
Limited Practitioner Expertise
The specialized nature of scleral lens fitting presents another hurdle. Only about 15% of optometrists worldwide currently possess advanced fitting capabilities, creating access disparities particularly in rural and underserved regions. The learning curve for proper fitting techniques is steep, requiring additional training and investment in diagnostic instruments like corneal topographers. Many general practitioners hesitate to recommend scleral lenses due to concerns about potential complications like lens binding or insufficient tear exchange.
Patient Compliance Challenges
Maintenance requirements also impact adoption rates. Scleral lenses demand rigorous cleaning regimens and specialized solutions, with improper care potentially leading to microbial keratitis or other inflammatory responses. The larger lens size makes handling more difficult for patients with dexterity issues, while inconsistent wear durations due to discomfort may compromise therapeutic benefits.
Expanding Applications in Therapeutic and Cosmetic Segments
The scleral lens market presents significant untapped potential in both medical and cosmetic domains. Beyond traditional refractive correction, these lenses show promise for managing ocular surface diseases like Stevens-Johnson syndrome and graft-versus-host disease. Emerging applications include postsurgical rehabilitation following corneal transplants or LASIK complications, where standard lenses prove inadequate. The cosmetic segment is witnessing growth as well, with tinted and prosthetic scleral lenses gaining popularity for managing disfiguring conditions like aniridia or traumatic eye injuries. Manufacturers exploring these therapeutic and aesthetic applications can capitalize on less saturated market segments with higher willingness-to-pay.
➤ Recent clinical studies demonstrate scleral lenses' effectiveness in reducing pain and improving visual function for 89% of patients with severe dry eye syndrome unresponsive to other treatments.
Geographic expansion represents another lucrative opportunity. While North America currently dominates with over 40% market share, Asia-Pacific shows the fastest growth potential due to increasing healthcare spending and rising awareness about advanced vision correction options. Localized product offerings tailored to regional anatomical differences and pricing sensitivities could unlock substantial growth in these developing markets.
Regulatory Hurdles and Reimbursement Uncertainties
The scleral lens industry faces ongoing regulatory complexities that impact product development and market access. Classification variances across regions create compliance challenges; while some countries regulate these devices as Class II medical devices, others impose stricter Class III requirements. Obtaining approvals for new materials or designs often involves lengthy clinical evaluations, delaying time-to-market. Reimbursement policies remain inconsistent, with coding ambiguities leading to claim denials even for medically indicated cases. The lack of standardized coverage criteria forces patients to bear substantial out-of-pocket costs, suppressing market growth despite clear clinical benefits.
Competitive Pressure from Alternative Technologies
Emerging technologies pose competitive threats to traditional scleral lenses. Advancements in corneal cross-linking procedures for keratoconus and improved soft lens materials for dry eye could reduce dependence on scleral options. The development of bioengineered corneal tissues and stem cell therapies may eventually disrupt the therapeutic lens market segment. Manufacturers must accelerate innovation to maintain relevance as alternative treatment modalities evolve.
Supply Chain Vulnerabilities
Specialized material requirements create supply chain risks. Many high-performance polymers used in scleral lenses come from limited suppliers, making production susceptible to disruptions. The precision manufacturing process requires controlled environments and skilled technicians, complicating capacity scaling to meet growing demand. These operational challenges could hinder market responsiveness during periods of rapid growth or unexpected demand surges.
Mini-Scleral Lenses Dominate the Market Due to Their Balance of Comfort and Clinical Application
The market is segmented based on type into:
Mini-Scleral Lenses
Large-Scleral Lenses
Hospital Segment Leads Due to High Demand for Specialized Vision Correction Solutions
The market is segmented based on application into:
Hospital
Eye Clinic
Others
Gas-Permeable Materials Preferred for Their Superior Oxygen Transmission
The market is segmented based on material into:
Gas-Permeable
Hybrid
PMMA
Prosthetic Scleral Lenses Gaining Traction in Ocular Surface Rehabilitation
The market is segmented based on design into:
Therapeutic Lenses
Prosthetic Lenses
Cosmetic Lenses
Innovation and Strategic Expansion Drive Market Leadership in Scleral Lenses
The global scleral contact lenses market demonstrates a moderately fragmented competitive landscape, characterized by the presence of established multinational players and emerging regional specialists. Bausch Health and CooperVision collectively held over 28% of global market share in 2024, leveraging their extensive distribution networks and clinically validated lens technologies. These industry leaders continue to dominate due to their ability to address complex ocular conditions like keratoconus while maintaining strong physician relationships.
Meanwhile, BostonSight has emerged as a key innovator in custom scleral prosthetics, reporting 19% revenue growth in 2023 through its FDA-approved PROSE treatment system. Their patient-specific design approach has become the gold standard for irregular corneas, creating significant barriers to entry for smaller competitors. Similarly, SynergEyes strengthened its market position through hybrid lens technology that combines rigid center optics with soft lens peripherals - a design that reduced dropout rates by 37% in recent clinical studies.
The competitive intensity is further heightened by strategic acquisitions, such as Essilor's 2023 purchase of Paragon Vision Sciences' scleral lens division. This move not only expanded Essilor's medical portfolio but also granted immediate access to proprietary HDS (High Definition Scleral) lens manufacturing techniques. Smaller players like Art Optical and Valley Contax are responding by specializing in niche applications, particularly post-surgical and therapeutic lens solutions where customization commands premium pricing.
Bausch Health (U.S.)
CooperVision (U.S.)
BostonSight (U.S.)
Essilor (France)
SynergEyes (U.S.)
ABB Optical (U.S.)
Visionary Optics (U.S.)
Art Optical (U.S.)
Menicon (Japan)
Recent product launches demonstrate the industry's focus on material science innovations, with oxygen permeability (Dk) values now exceeding 180 units in premium lenses. However, the market faces regulatory challenges as the FDA increases scrutiny on long-term wear indications. Companies investing in post-market surveillance and real-world evidence generation, like Tru-Form Optics' 5-year patient registry study, are better positioned to navigate these requirements while building clinical credibility.
The global scleral contact lenses market is witnessing significant growth due to the increasing prevalence of corneal disorders such as keratoconus, corneal ectasia, and severe dry eye syndrome. Recent studies indicate that keratoconus alone affects approximately 1 in 2,000 individuals worldwide, creating substantial demand for vision correction solutions that standard lenses cannot address. Scleral lenses provide a unique solution by vaulting over the irregular cornea and resting on the sclera, offering improved comfort and visual acuity. Furthermore, advancements in lens materials with higher oxygen permeability (Dk values exceeding 150) have enhanced wearability, making them suitable for extended daily use up to 16 hours in some cases.
Technological Innovations in Lens Design
The market is experiencing a paradigm shift with CAD/CAM technology enabling fully customized scleral lenses tailored to individual ocular topography. This precision manufacturing has reduced fitting times by 30-40% compared to traditional methods while improving success rates for complex corneal conditions. Recent developments include hybrid designs combining rigid center optics with soft lens peripheries, addressing comfort challenges without compromising optical performance. Integration of wavefront-guided optics in premium scleral lenses now corrects higher-order aberrations beyond standard refractive errors, particularly beneficial for patients post-corneal transplants.
Scleral lenses are increasingly being adopted for therapeutic applications beyond vision correction. Ophthalmologists now utilize fluid-ventilated scleral lenses as protective shields for acute corneal injuries, with clinical studies showing 85% improvement in epithelial healing rates. The post-surgical segment is growing at 18% CAGR as these lenses demonstrate efficacy in managing complications from refractive surgeries. Emerging research also indicates their potential in drug delivery systems, where lens material modifications enable sustained release of ophthalmic medications over 72+ hours, presenting new opportunities in glaucoma and ocular inflammation management.
North America
The North American scleral contact lens market is characterized by advanced healthcare infrastructure and high adoption rates of specialized vision correction solutions. The region holds approximately 35% of the global market share, driven by factors such as increasing prevalence of keratoconus and other corneal disorders. The U.S. FDA's stringent approval process ensures product safety while encouraging innovation, with major players like Bausch Health and CooperVision leading R&D efforts. However, the market faces challenges from high product costs and limited insurance coverage for these premium lenses. Recent developments include the introduction of hybrid scleral lenses combining comfort with enhanced oxygen permeability.
Europe
Europe's market growth parallels North America's in technological sophistication but differs in its decentralized reimbursement policies across member states. Germany and the UK collectively account for over 40% of regional revenues, benefiting from well-established optometry networks and patient awareness programs. The European market is witnessing a surge in demand for mini-scleral lenses due to their easier adaptation process. Regulatory alignment under the EU Medical Devices Regulation (MDR) has standardized quality requirements while slowing product approvals. Market expansion is further constrained by conservative prescribing habits among some ophthalmologists preferring traditional correction methods.
Asia-Pacific
As the fastest-growing regional market projected at 18.3% CAGR, Asia-Pacific demonstrates exceptional potential fueled by China's expanding middle class and India's underserved refractive error population. Japan leads in technological adoption with customized scleral lenses gaining popularity in urban centers. Nevertheless, the region faces unique challenges including price sensitivity limiting premium product uptake and cultural preferences for spectacles over contact lenses. Emerging manufacturing hubs in South Korea and Taiwan are lowering production costs, making scleral lenses more accessible. The lack of specialized fitters outside metropolitan areas remains a key growth barrier.
South America
Market development in South America remains nascent but promising, with Brazil and Argentina showing increased willingness to adopt advanced vision correction technologies. Economic instability periodically disrupts supply chains and affects affordability, though local manufacturers are emerging to address cost concerns. The region demonstrates particular interest in post-surgical and therapeutic applications of scleral lenses, especially for corneal transplants. Regulatory frameworks vary significantly between countries, with Argentina having more structured approval processes compared to others. Professional training programs are gradually expanding to improve fitting expertise.
Middle East & Africa
This region presents contrasting scenarios - while Gulf Cooperation Council (GCC) countries demonstrate advanced adoption mirroring Western markets, Sub-Saharan Africa lags due to infrastructure limitations. The UAE and Saudi Arabia collectively represent over 60% of regional demand, driven by medical tourism and high disposable incomes. Market growth is hindered by limited local manufacturing and reliance on imports leading to higher prices. Recent developments include university-hospital partnerships in Morocco and South Africa to train specialists in complex fittings. The potential remains largely untapped, particularly for managing tropical eye diseases where scleral lenses could offer therapeutic benefits.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include ABB Optical, Bausch Health, Visionary Optics, Essilor, Art Optical, CooperVision, BostonSight, AccuLens, Tru-Form Optics, and SynergEyes, among others.
-> Key growth drivers include rising prevalence of corneal disorders, technological advancements in lens materials, and increasing demand for specialty contact lenses.
-> North America currently holds the largest market share, while Asia-Pacific is expected to witness the highest growth rate during the forecast period.
-> Emerging trends include development of hybrid scleral lenses, integration of smart technology for monitoring eye health, and increasing focus on custom-fit solutions.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
